共 50 条
- [21] Financial Situation of Listed Companies in Pharmaceutical Industry [J]. PROCEEDINGS OF THE FIFTH SYMPOSIUM OF RISK ANALYSIS AND RISK MANAGEMENT IN WESTERN CHINA (WRARM 2017), 2017, 152 : 110 - 114
- [22] Research on the Influence of Listed Company Financial Incentive on the Value Creation Ability [J]. 2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING, MSE 2015, 2015, : 273 - 280
- [23] DETERMINANTS OF THE ADOPTION OF THE AUDIT COMMITTEE IN BRAZILIAN COMPANIES LISTED ON B3 [J]. REVISTA GESTAO ORGANIZACIONAL, 2018, 11 (02): : 26 - 39
- [25] THE RELEVANCE OF FINANCIAL INFORMATION ON B3 LISTED COMPANIES ACTING WITH BIOLOGICAL ASSETS AFTER ADOPTION OF CPC 29 [J]. REVISTA DE GESTAO FINANCAS E CONTABILIDADE, 2018, 8 (02): : 5 - 22
- [26] Classification of agribusiness companies listed on the B3 according to their competitive advantages [J]. CUSTOS E AGRONEGOCIO ON LINE, 2018, 14 (04): : 444 - 466
- [27] Corporate Sustainability and Executive Compensation: An Analysis in Companies Listed on B3 [J]. REUNIR-REVISTA DE ADMINISTRACAO CONTABILIDADE E SUSTENTABILIDADE, 2022, 12 (01): : 75 - 86
- [28] The effects of CPC 47 on earnings management in companies listed in B3 [J]. REVISTA AMBIENTE CONTABIL, 2023, 15 (01): : 154 - 179
- [29] EBITDA VERSUS OPERATING CASH FLOW AT COMPANIES LISTED AT B3 [J]. REVISTA CONTABILIDADE E CONTROLADORIA-RC C, 2021, 13 (03): : 131 - 149
- [30] Reflection of Tax Planning in the Debt of Non-Financial Companies Listed in Brasil Bolsa Balcao (B3) [J]. REVISTA DE GESTAO E SECRETARIADO-GESEC, 2021, 12 (02): : 225 - 252